Jim Frakes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aethlon Medical Announces Pricing of $4 7 Million Public Offering

Aethlon Medical Announces Pricing of $4 7 Million Public Offering
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJim frakesSusan noonanCompany contactSecurities exchangeExchange commissionMaxim groupAethlon medical incCompany annual report on formPrnewswire aethlon medical incProspectus departmentSa noonan communicationsDrug administrationMedical announces pricingBreakthrough device

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4 7 Million Public Offering

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4 7 Million Public Offering
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSusan noonanJim frakesMaxim groupAthelon medical incDrug administrationSecurities exchangeExchange commissionNewswire aethlon medical incSa noonan communicationsCompany annual report on formCompany contactProspectus departmentAethlon medical incAethlon medical

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

James frakesJim frakesSusan noonanCellarcus biosciences incAthelon medical incSecurities exchangeSa noonan communicationsExchange commissionAethlon medical incNewswire aethlon medical incDrug administrationCompany annual report on formCompany contactAethlon medicalInterim chief executive officerChief financial officer

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jim frakesSusan noonanJames frakesCellarcus biosciences incDrug administrationPrnewswire aethlon medical incExchange commissionSecurities exchangeSa noonan communicationsCompany annual report on formCompany contactAethlon medical incSupport the designInterim chief executive officerChief financial officerCellarcus biosciences

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG s NucleoCapture and HemoNucleoCapture Devices

/PRNewswire/ Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening.

City ofUnited kingdomJames frakesSusan noonanSantersu nucleocaptureAethlon hemopurifierScott maguireJim frakesSecurities exchangeExchange commissionCompany contactAethlon medical incSa noonan communicationsDrug administrationPrnewswire aethlon medical incCompany annual report on form